PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
9.08%
Revenue growth at 75-90% of ADI's 10.82%. Bill Ackman would push for innovation or market expansion to catch up.
12.14%
Gross profit growth at 50-75% of ADI's 17.92%. Martin Whitman would question if cost structure or brand is lagging.
15.73%
EBIT growth below 50% of ADI's 43.56%. Michael Burry would suspect deeper competitive or cost structure issues.
16.53%
Operating income growth under 50% of ADI's 43.56%. Michael Burry would be concerned about deeper cost or sales issues.
16.87%
Net income growth under 50% of ADI's 38.75%. Michael Burry would suspect the firm is falling well behind a key competitor.
18.87%
EPS growth at 50-75% of ADI's 36.59%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
19.23%
Diluted EPS growth at 50-75% of ADI's 37.50%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
-2.03%
Share reduction while ADI is at 0.80%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-2.01%
Reduced diluted shares while ADI is at 0.36%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.70%
Dividend growth above 1.5x ADI's 0.36%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
-20.85%
Negative OCF growth while ADI is at 30.19%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-43.18%
Negative FCF growth while ADI is at 32.67%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
74.35%
10Y revenue/share CAGR above 1.5x ADI's 36.21%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
45.91%
5Y revenue/share CAGR 1.25-1.5x ADI's 37.76%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
21.46%
3Y revenue/share CAGR above 1.5x ADI's 10.65%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
24.50%
10Y OCF/share CAGR under 50% of ADI's 114.03%. Michael Burry would worry about a persistent underperformance in cash creation.
-8.14%
Negative 5Y OCF/share CAGR while ADI is at 97.71%. Joel Greenblatt would question the firm’s operational model or cost structure.
-25.55%
Negative 3Y OCF/share CAGR while ADI stands at 29.23%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-15.87%
Negative 10Y net income/share CAGR while ADI is at 62.18%. Joel Greenblatt sees a major red flag in long-term profit erosion.
65.53%
5Y net income/share CAGR at 75-90% of ADI's 76.89%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
49.96%
3Y net income/share CAGR similar to ADI's 47.73%. Walter Schloss would attribute it to shared growth factors or demand patterns.
9.16%
Below 50% of ADI's 83.32%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
15.04%
Positive 5Y equity/share CAGR while ADI is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
0.96%
Below 50% of ADI's 4.51%. Michael Burry suspects a serious short-term disadvantage in building book value.
513.01%
Dividend/share CAGR of 513.01% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
384.68%
5Y dividend/share CAGR above 1.5x ADI's 233.03%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
52.06%
3Y dividend/share CAGR above 1.5x ADI's 10.79%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
12.39%
AR growth well above ADI's 6.02%. Michael Burry fears inflated revenue or higher default risk in the near future.
5.72%
Inventory growth well above ADI's 1.80%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-1.67%
Negative asset growth while ADI invests at 6.22%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
1.55%
Under 50% of ADI's 3.73%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
No Data
No Data available this quarter, please select a different quarter.
5.95%
R&D growth drastically higher vs. ADI's 7.33%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
5.29%
SG&A growth well above ADI's 10.37%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.